Recombinant Human MRTFA Protein ，His & KSI

MRTFA (Myocardin-related transcription factor A) is a member of the MRTF family, crucial in regulating gene expression associated with smooth muscle and cardiac development. It functions as a signaling hub that integrates cues from mechanical stimuli and cytoskeletal dynamics to modulate transcriptional programs, particularly those governing vascular smooth muscle cell contractility and plasticity. Recent studies have highlighted its role in various physiological processes, such as vascular homeostasis and response to injury, as well as its involvement in pathological conditions including hypertension and atherosclerosis. Given its significance, researchers have focused on the biochemical and biophysical characterization of MRTFA, exploring its regulatory mechanisms, post-translational modifications, and interaction with other signaling molecules. The production of recombinant MRTFA proteins for in vitro studies has become a pivotal aspect of this research, enabling a deeper understanding of its functional mechanisms and potential therapeutic targets. By elucidating the structure-function relationships of MRTFA, researchers aim to uncover novel strategies to manipulate its activity for therapeutic benefits, potentially providing new avenues for treating cardiovascular diseases. Thus, the study of MRTFA and its recombinant forms not only contributes to the fundamental knowledge of smooth muscle biology but also holds promise for developing innovative treatments in cardiovascular medicine.